简体
  • 简体中文
  • 繁体中文

热门资讯> 正文

花旗发布90天催化剂观察,Dynatrace成为焦点

2026-08-18 19:48

  • Dynatrace (DT) was in focus on Tuesday as Citi issued a 90-day catalyst watch on the AI observability company. 
  • Shares rose 1.1% in premarket trading.
  • “DT has underperformed since reporting a robust/re-accelerating F1Q27 (-6% since print; +10% YTD) and more recently following its largest acquisition to-date ($915M 22x EV/S for Arize AI),” Citi analyst Fatima Boolani wrote in a note to clients. “At [the] current 5x EV/S, 19x EV/FCF’27, DT’s not only compelling on an absolute basis, but on a relative (DDOG 11-turn/38-turn premium), and even historical basis (5-year medians 8x EV/S, 33x EV/FCF). This not only undermines solid transaction rationale, but also a faster path back to ~20% ARR CAGR [medium-term], which in aggregate warrants multiple expansion against estimate acceleration/positive revisions, in our view. Combined with an upcoming investor day (C4Q) against activist involvement (Starboard), broader software sector M&A appetite heating up (DT is a strategic asset in an attractive end-market), and a capital raise (affording potentially better repurchase optionality), we’re reaffirming Buy, lifting PT to $65 on revised CitiE (topline up [medium-term], margins lower near-term) on unchanged multiples, and initiating a positive Catalyst Watch.”

风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。